Navigation Links
Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology
Date:1/31/2008

Researchers in South Africa latest to report patient benefits

SUNNYVALE, Calif., Jan. 31 /PRNewswire/ -- Starion Instruments, a leading surgical device company, today announced that it has extended worldwide distribution of its proprietary tissue welding technology. Physicians in North America, Europe, the Middle East, Africa, and Asia now have access to safe, effective and precise instruments for a wide variety of surgical procedures.

Sealing and dividing soft tissue is an essential part of surgery. Unlike conventional products which use indirect forms of energy: ultrasonic or bipolar radio frequency, Starion instruments perform sealing and dividing with direct heat and pressure. Studies have shown that this method minimizes thermal spread, reduces the risk of collateral damage and decreases patient recovery times.

"Surgeons worldwide are demanding technologies that enhance performance, minimize risk and improve patient outcomes," said Kirt Kirtland, president and chief executive officer of Starion Instruments. "We are excited that our products and value proposition have expanded our reach across the globe."

In South Africa, for example, surgeons are using the company's products in a wide variety of cardiology, general surgery, gynecology, and otolaryngology procedures. The next anticipated areas of expansion are China and Japan, where regulatory approvals are pending.

As Starion's influence grows beyond the U.S., leading researchers from Greece to Taiwan are reporting the benefits of tissue welding technology versus other modalities. Most recently, Lance Maron, MBBCh, FCS (SA), from Netcare Parklane Hospital in Johannesburg, South Africa, presented his findings at the 43rd South African National ENT & SAHNOS Congress.

During the Congress, Maron reported that Starion's forceps are easy to use, cause minimal intra-operative blood loss, facilitate complete removal of tonsils resulting in rapid healing and recovery w
'/>"/>

SOURCE Starion Instruments
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
2. Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial
3. Pharsight Achieves $7.4 Million in Quarterly Revenue
4. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
5. BIAS Achieves Certified Advantage Partner Level in Oracle PartnerNetwork
6. NOLabs AB Achieves Break-Through in Fight Against MRSA-Bacteria
7. Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
8. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
9. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
10. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
11. Signalife Achieves $1.98 Million Sales Orders Thus Far

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:...today announced updated results from a Phase II st...rcomas metastatic to the lung in a poster presenta... Society Meeting held in Miami Beach, Florida, fro...titled "A Phase II Study of Intravenous REOLYSIN (...
(Date:11/5/2009)...ov. 5 The endangered black-footed ....S. This rare carnivore feeds on prairie dogs. ...d often entire population die-offs in towns occur....mplemented a ferret breeding program and has been ...erly native habitat. Unfortunately, plague can sw...
(Date:11/5/2009)... Transgenomic, Inc. (OTC ...sults for the quarter ended September 30, 2009. Th... tables that follow. ,, Third Quarter 2009 ,... $0.01 per share for the third quarter of 2009 as ...are for the third quarter of 2008. ,, Net sale...
(Date:11/5/2009).... 5 WaferGen Biosystems,...per of state-of-the-art genetic analysis systems, ...joined the company,s Scientific Advisory Board. H...cializing novel molecular diagnostics for cancer d...pment of computational biology systems for several...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
..., , , Andreas Hhmer, Helen Tran, and Wil... , , Protein Oxidation , The...rmo Finnigan LCQTMion , trap mass spectrome...troduction , , Calmodulin (CaM) is..., present in most eukaryotic cells. It regu...
... , , GenoVision AS, an innovative biotechn...automation for the isolation and purification , ...roup of Companies and is now , known as QIA...hput purification , of DNA and , RNA...MagAttract magnetic-bead , technology in co...
... , , For transfection of cells with siRNA..., Features and benefits , , , , ...nsfection of siRNA for effective gene silencing ,...-to-use reagent , Tested for absence of... Principle , , , , , , Tr...
Other Biology Technology:Identification of Low-Level Oxidation Products in Calmodulin Using NanoSpray , Ion Trap Mass Spectrometry 2Identification of Low-Level Oxidation Products in Calmodulin Using NanoSpray , Ion Trap Mass Spectrometry 3Identification of Low-Level Oxidation Products in Calmodulin Using NanoSpray , Ion Trap Mass Spectrometry 4Identification of Low-Level Oxidation Products in Calmodulin Using NanoSpray , Ion Trap Mass Spectrometry 5Identification of Low-Level Oxidation Products in Calmodulin Using NanoSpray , Ion Trap Mass Spectrometry 6Walkaway automation for nucleic acid purification 2TransMessenger Transfection Reagent 2TransMessenger Transfection Reagent 3
(Date:11/4/2009)...scientists are reluctant to officially endorse gre...tinues to grow about its protective effects, inclu...revention Research , a journal of the American Ass...reduction in oral cancer. , Vassiliki Papadimit...rtment of Thoracic/Head and Neck Medical Oncology ...
(Date:11/4/2009)... in the cities of Long Beach and Riverside are res...le childhood asthma, and the true impact of air po...ly been underestimated, according to researchers a... The study, which appears in an online edition of...d that nine percent of all childhood asthma cases ...
(Date:11/4/2009)...acteria, it turns out, hold the power to help mili...he world clean up toxic waste on test sites. , C...re invented back in World War II and have been use...nergy compounds are often used to propel tank shel..., But with increased knowledge of their environm...
Breaking Biology News(10 mins):Does green tea prevent cancer? Evidence continues to brew, but questions remain 2USC study finds big air pollution impacts on local communities 2Genomic research will enable greener cleanup of military explosive test sites 2Harrison City ROCKS 21 Set for August 15 Music Festival to Benefit Cardiac Research at Childrens Hospital of Pittsburgh 53340 1NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results 13308 1NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results 13308 2NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results 13308 3Gene Found for Age Related Cataract 53336 1
... is available in German . , A group of antibiot...ntre for Infection Research (HZI) in Braunschweig ... bacteria. Isolated from myxobacteria, the substan...ble to translate their genetic material. In this w...sis pathogens - is inhibited. A working group at R...
...roperty Inventory for Biometric Identity Managemen...N.J., Oct. 15 BIO-key International,Inc. (OTC Bul...tric,identification and wireless public safety, an...ffice has approved the issuance of a patent for th...rity" method., This recently issued "Biometric Id...
..., the maverick geologist who convinced a skeptical... on Earth were wiped out by a huge fireball from s...Considered by many the earth sciences, equivalent ...w York-based G. Unger Vetlesen Foundation and admi...mber of Columbia University,s Earth Institute. , ...
Other Biology News:New antibiotic candidates from Braunschweig 2New antibiotic candidates from Braunschweig 3BIO-key(R) Granted Additional Patent for Biometric Security Solution 2BIO-key(R) Granted Additional Patent for Biometric Security Solution 3Geologist who linked cosmic strike to dinosaurs' extinction takes top prize 2Geologist who linked cosmic strike to dinosaurs' extinction takes top prize 3
Zymoclean Gel DNA Recovery Kit from Zymo Research
Rabbit Complement from Equitech-Bio
Stat-Pack Sputolysin Reagent from Caldon Biotech, Inc.
UltraClean 15 Kit from Mo Bio Laboratories, Inc.
Biology Products: